Changzhou Qianhong Bio-pharma Co. Ltd., of Changzhou, China, said it started phase two construction of its pharmaceuticals production facility at Changzhou National Hi-tech District involving an investment of ¥1 billion (US$145.8 million). The facility will focus on the research and development of innovative and first-of-its-class-in-China biological drugs.